Avery W. Catlin
2011
In 2011, Avery W. Catlin earned a total compensation of $506.7K as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $140,608 |
| Salary | $295,544 |
| Other | $5,572 |
| Total | $506,724 |
Catlin received $295.5K in salary, accounting for 58% of the total pay in 2011.
Catlin also received $65K in bonus, $140.6K in option awards and $5.6K in other compensation.
Rankings
In 2011, Avery W. Catlin's compensation ranked 7,989th out of 10,747 executives tracked by ExecPay. In other words, Catlin earned more than 25.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,989 out of 10,747 | 26th |
Division Manufacturing | 2,932 out of 3,960 | 26th |
Major group Chemicals And Allied Products | 734 out of 1,038 | 29th |
Industry group Drugs | 525 out of 786 | 33rd |
Industry In Vitro and In Vivo Diagnostic Substances | 26 out of 43 | 40th |
Source: SEC filing on April 9, 2014.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2011.